β2-AR signaling controls trastuzumab resistance-dependent pathway.
Liu D, Yang Z, Wang T, Yang Z, Chen H, Hu Y, Hu C, Guo L, Deng Q, Liu Y, Yu M, Shi M, Du N, Guo N.
Liu D, et al.
Oncogene. 2016 Jan 7;35(1):47-58. doi: 10.1038/onc.2015.58. Epub 2015 Mar 23.
Oncogene. 2016.
PMID: 25798840